MYGN ▲ +11.3% - Myriad Genetics, Inc.
$MYGN - Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives
04-NOV-2026 04:05 PM ET
Share this post
More filings for $MYGN
MYGN ▼ -7.6% - Myriad Genetics, Inc.Nov 2, 2026MYGN - Myriad Genetics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026MYGN ▼ -1.8% - Myriad Genetics, Inc.Oct 22, 2026MYGN ▲ +10.7% - Myriad Genetics, Inc.Oct 20, 2026MYGN ▲ +10.7% - Myriad Genetics, Inc.Oct 20, 2026MYGN ▲ +4.8% - Myriad Genetics, Inc.Oct 15, 2026
View full $MYGN filing history →💬 Comments
Loading comments…
Leave a comment